GE HealthCare Technologies Inc (GEHC)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | Mr. Kevin A. LoboIndependent Director | 10.00k | 641.80k | 買い | 64.18 | 14.36k | 229.20% |
| 2026-05-15 | Ms. Jeannette BankesPresident & CEO of Patient Care Solutions | -5.54k | 346.88k | Sale to Issuer | 62.67 | 38.36k | -12.61% |
| 2026-05-12 | Dr. Rodney F. HochmanLead Independent Director | 1.62k | 100.36k | 買い | 62.03 | 21.50k | 8.14% |
| 2026-05-08 | Ms. Phoebe L. Yang WatkinIndependent Director | 1,000.00 | 63.01k | 買い | 63.01 | 1,000.00 | - |
| 2026-05-06 | Mr. H. Lawrence CulpIndependent Chairman | 80.81k | 5.00M | 買い | 61.88 | 492.17k | 19.64% |
| 2026-05-06 | Mr. William J. StrombergIndependent Director | 1,000.00 | 61.69k | 買い | 61.69 | 1,000.00 | - |
| 2026-05-01 | Mr. James K. SaccaroVP & CFO | 3.31k | 200.59k | 買い | 60.60 | 52.81k | 6.69% |
| 2026-04-30 | Mr. Frank R. JimenezGeneral Counsel & Corporate Secretary | 1.75k | 105.79k | 買い | 60.45 | 62.62k | 2.87% |
| 2026-04-30 | Mr. Peter J. ArduiniPresident, CEO & Director | 4.17k | 249.83k | 買い | 59.93 | 130.58k | 3.30% |
| 2026-02-12 | Mr. Kevin Michael O’NeillPresident & CEO of Pharmaceutical Diagnostics | -3.26k | 258.27k | Sale to Issuer | 79.20 | 18.22k | -15.18% |
| 2026-02-12 | Mr. George Andrew NewcombController & CAO | -802.00 | 63.52k | Sale to Issuer | 79.20 | 7.00k | -10.28% |
| 2026-02-12 | Mr. Roland Rottインサイダー | -3.94k | 312.29k | Sale to Issuer | 79.20 | 18.48k | -17.59% |
| 2026-02-12 | Mr. Philip D. RackliffePresident & CEO of Advanced Imaging Solutions (AIS) | -1.17k | 92.98k | Sale to Issuer | 79.20 | 9.62k | -10.88% |
| 2026-02-12 | Dr. Taha Kass-HoutChief Science & Technology Officer | -7.79k | 616.73k | Sale to Issuer | 79.20 | 57.23k | -11.98% |
| 2026-02-12 | Mr. Frank R. JimenezGeneral Counsel & Corporate Secretary | -8.36k | 661.87k | Sale to Issuer | 79.20 | 60.87k | -12.07% |
| 2026-02-12 | Mr. Peter J. ArduiniPresident, CEO & Director | -33.45k | 2.65M | Sale to Issuer | 79.20 | 126.41k | -20.92% |
| 2026-02-12 | Mr. James K. SaccaroVP & CFO | -8.57k | 678.74k | Sale to Issuer | 79.20 | 49.50k | -14.76% |
| 2026-02-01 | Mr. Kevin Michael O’NeillPresident & CEO of Pharmaceutical Diagnostics | -462.00 | 36.48k | Sale to Issuer | 78.97 | 14.54k | -3.08% |
| 2026-02-01 | Mr. Philip D. RackliffePresident & CEO of Advanced Imaging Solutions (AIS) | -189.00 | 14.93k | Sale to Issuer | 78.97 | 7.64k | -2.42% |
| 2026-02-01 | Dr. Taha Kass-HoutChief Science & Technology Officer | -847.00 | 66.89k | Sale to Issuer | 78.97 | 41.68k | -1.99% |
| 2026-02-01 | Mr. George Andrew NewcombController & CAO | -108.00 | 8.53k | Sale to Issuer | 78.97 | 5.28k | -2.00% |
| 2026-02-01 | Mr. Roland Rottインサイダー | -558.00 | 44.07k | Sale to Issuer | 78.97 | 14.54k | -3.70% |
| 2026-02-01 | Mr. Frank R. JimenezGeneral Counsel & Corporate Secretary | -947.00 | 74.78k | Sale to Issuer | 78.97 | 47.15k | -1.97% |
| 2026-02-01 | Mr. James K. SaccaroVP & CFO | -948.00 | 74.86k | Sale to Issuer | 78.97 | 35.46k | -2.60% |
| 2026-02-01 | Mr. Peter J. ArduiniPresident, CEO & Director | -3.21k | 253.49k | Sale to Issuer | 78.97 | 84.95k | -3.64% |
| 2025-09-11 | Mr. Roland Rottインサイダー | 721.00 | 40.04k | Derivative Exercise and Retained Stock | 51.67 - 57.74 | 13.98k | 5.44% |
| 2025-09-11 | Mr. Roland Rottインサイダー | -4.62k | 95.71k | Derivative Exercise and Sale | 51.67 - 76.68 | 13.98k | - |
| 2025-09-01 | Mr. Kenneth R. StacherskiChief Global Supply Chain & Service Officer | -892.00 | 65.77k | Sale to Issuer | 73.73 | 19.53k | -4.37% |
| 2025-09-01 | Mr. Adam Y. HoltonCPO | -464.00 | 34.21k | Sale to Issuer | 73.73 | 987.00 | -31.98% |
| 2025-09-01 | Dr. Taha Kass-HoutChief Science & Technology Officer | -2.90k | 213.60k | Sale to Issuer | 73.73 | 39.22k | -6.88% |
| 2025-09-01 | Mr. Philip D. RackliffePresident & CEO of Advanced Imaging Solutions (AIS) | -1.89k | 139.42k | Sale to Issuer | 73.73 | 7.37k | -20.42% |
| 2025-09-01 | Mr. Roland Rottインサイダー | -1.83k | 135.22k | Sale to Issuer | 73.73 | 13.26k | -12.15% |
| 2025-09-01 | Mr. Frank R. JimenezGeneral Counsel & Corporate Secretary | -3.08k | 227.01k | Sale to Issuer | 73.73 | 44.97k | -6.41% |
| 2025-09-01 | Mr. James K. SaccaroVP & CFO | -3.24k | 238.74k | Sale to Issuer | 73.73 | 33.43k | -8.83% |
| 2025-09-01 | Mr. Peter J. ArduiniPresident, CEO & Director | -11.35k | 836.54k | Sale to Issuer | 73.73 | 77.45k | -12.78% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。